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This presentation gave an introduction to the legal
background in Switzerland and the informed consent
process adopted in the CoLaus study. The information
covered the scope of study, risks and benefits of partici-
pation, confidentiality of data, collaboration with acade-
mia, industry and their partners, potential shipment of
the samples to other collaborators, right to withdrawal,
right to have samples destroyed. There were no rights
to financial benefits and genetic data for the individual
participant. The limitations of the consent included the
broad definition of study areas and the potential conflict
with right to information in future.
Collaboration with local ethics committees is impor-
tant with strict protocols. Ethics committee should be
informed and updated of the constant progress of tech-
nologies and feed-back from investigators.
Collaboration with industry had the benefits of signifi-
cant financial input, high standards and long experience
with ethical committees , long experience with material
and data transfer contracts and bio-bank and database
organization. The disadvantages included lengthy con-
tracts, complicated legal issues and the negative attitude of
some subjects towards involvement of pharmaceutical
companies. The experience with industrial collaboration
reinforces the need for transparency in all procedures, reg-
ular conferences and a strong legal department in the aca-
demic institution. Ethical dilemmas included the public
availability of individual genetic data, return of genetic
data to the subject and the need of multi-layered consent.
CoLaus investigators decided that in general no individual
data would be made publicly available.
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